Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK PM Warns Of Tougher Measures Ahead, Calls For "Maximum Vigilance"

Mon, 11th Jan 2021 16:25

(Alliance News) - UK Prime Minister Boris Johnson has warned that tougher lockdown measures may be needed as he announced that around 2.4 million vaccines for Covid-19 have now been put in people's arms in the UK.

The prime minister stressed "now is the moment for maximum vigilance" amid increasing calls for tougher lockdown restrictions as case rates soar in several parts of the country.

During a visit to a vaccine centre in Ashton Gate Stadium, Bristol, the prime minister said: "We're going to keep the rules under constant review.

"Where we have to tighten them, we will.

"We have rules in place already which, if they are properly followed, we believe can make a huge, huge difference.

"It's now that people need to focus...when they're out shopping, whether they're buying cups of coffee in the park or whatever it happens to be, they need to think about spreading the disease."

Johnson said that "more important than us just pushing out new rules", people should follow existing guidance.

"In supermarkets, people need to be keeping their distance, making sure that they're wearing masks, doing the right thing.

"We need to enforce the rules in supermarkets. When people are getting takeaway drinks, in cafes, then they need to avoid spreading the disease there, avoid mingling too much.

"Now is the moment for maximum vigilance, maximum observance of the rules.

"Of course, if we feel that things are not being properly observed then we may have to do more."

Turning to vaccines, the prime minister said roughly 40% of the 80-year-olds in the UK have now been vaccinated, with around 23% of the elderly residents of care homes having been inoculated.

He said around two million people overall have received a vaccine and "maybe a bit more".

He added: "We're at about 2.4 million jabs all in across the whole of the UK."

Among those calling for tougher lockdown rules is Labour leader Keir Starmer, who told reporters the country is "at the most serious stage" of the pandemic "and that calls for the most serious restrictions".

Starmer said: "There probably is more that we could do.

"An example is the question of whether nurseries should be open."

It comes as Chris Whitty, England's chief medical officer, warned the UK has not yet hit the peak of the current wave of Covid-19 infections, with the next few weeks being "the worst" of the pandemic for the NHS.

He said the vaccine rollout offered hope that lockdown restrictions could be lifted in the coming months but described the current UK death and case rate as an "appalling situation".

During a BBC phone-in on the current high case rates, he said: "I don't think we're yet at the peak, I'm afraid.

"I think we will be at the peak if everybody can double down and absolutely minimise their contacts.

"The point of the lockdown is to bring that forward, but it only works if everyone really thinks about every individual interaction they have and try and minimise them."

Whitty said the new variant of coronavirus was causing a "significant problem", telling BBC Breakfast: "We will get through together but at this point in time we're at the worst point in the epidemic for the UK."

Currently, around one in 50 people in England is infected.

Whitty said: "There's a very high chance that if you meet someone unnecessarily they will have Covid."

He added: "This is the most dangerous time we have really had in terms of numbers into the NHS at this particular time."

Asked if coronavirus is being spread outdoors, Whitty said the risks were much lower than for indoors, but said problems could occur if people gathered in groups, such as huddled round a market stall.

Pressed on whether people should wear masks in all outdoor settings, he said the most important thing was actually that people stayed home unless their journey was essential.

"I think that the much more important thing is that people should not be leaving their home unless they absolutely have to," he said.

"And where they do, try and keep their distance from people."

He added: "In a sense tinkering with the rules may be useful, but the far more important thing is that everybody abides by the spirit of the rules that are there at the moment."

It comes as seven mass vaccination centres open across England in a drive to ramp up the rollout of coronavirus vaccines from Pfizer Inc and AstraZeneca PLC.

The government aims to hit a target of vaccinating around 15 million people at highest risk of death and severe disease by the middle of February.

The new centres – including at a football stadium and a tennis club – will be joined later this week by hundreds more GP-led and hospital services along with the first pharmacy-led pilot sites, taking the total in England to around 1,200.

Overall there will be 2,700 vaccine sites across the UK, according to the government vaccine rollout plan.

The document sets out plans to vaccinate at least two million people a week, with ministers pledging that "tens of millions will be immunised by spring".

It also suggests that "those delivering key public services" and others at high risk of exposure could be next in line for the vaccine once the at-risk priority groups have been vaccinated.

By Jane Kirby, PA Health Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.